← Open Payments lookup

MIRANDA ENGELDINGER: Open Payments

NPI 1699456087 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$940 in 74 payments from 13 companies in 2025. Trend: 2023 $408 · 2024 $1,076 · 2025 $940

Food & beverage: $940
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.29$331
ABBVIE INC.22$210
Teva Pharmaceuticals USA, Inc.3$60
Neurocrine BioSciences, Inc.3$58
Corium, LLC4$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47
Alkermes, Inc.2$40
Janssen Pharmaceuticals, Inc2$35
MDD US Operations, LLC2$29
Neos Therapeutics, LP2$29

Products named: VRAYLAR, REXULTI, ABILIFY ASIMTUFII, INGREZZA, ABILIFY MAINTENA, Azstarys, CAPLYTA, ARISTADA.

Industry payments across IA — which companies pay providers there.